Overgrowth of Enterococcus faecium in the feces of patients with hematologic malignancies

Clinical Infectious Diseases

Volumn 23, Issue 4, 1996, Pages 694-697

  Suppola, Juhana P ^a   Volin, Liisa ^b   Valtonen, Ville V ^b   Vaara, Martti ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; CARBAPENEM DERIVATIVE; CEFOTAXIME; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; NITROIMIDAZOLE DERIVATIVE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIAL OVERGROWTH; BACTERIUM ISOLATION; CANCER PATIENT; ENTEROCOCCUS FAECALIS; FECES ANALYSIS; HOSPITAL INFECTION; HUMAN; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0029742854     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/23.4.694     Document Type: Article

References (9)

1. Moellering RC Jr. Emergence of Enterococcus as a significant pathogen. Clin Infect Dis 1992;14:1173-6.
2. Boyle JF, Soumakis SA, Rendo A, et al. Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci. J Clin Microbiol 1993:31:1280-5.
3. Noskin GA, Peterson LR, Warren JR. Enterococcus faecium and Enterococcus faecalis bacteremia: acquisition and outcome. Clin Infect Dis 1995;20:296-301.
4. Berger PS, Nash HD, Olson BH, Parr TR, Rosenberg B, Twillman RE. Tests for the fecal streptococcus group. In: Greenberg AE, Trussell LL, Clesceri LS, eds. Standard methods for the examination of water and wastewater. 16th ed. Washington, DC: American Public Health Association, 1985:902-9.
5. Facklam RR, Collins MD. Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol 1989; 27:731-4.
6. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. NCCLS document M100-S5. Villanova, Pennsylvania: National Committee for Clinical Laboratory Standards, 1994.
7. Casals JB, Pringler N. Antibacterial and antifungal susceptibility testing using Neo Sensitabs. 9th ed. Taastrup, Denmark: Rosco Diagnostica, 1991.
8. Bryan LE, Godfrey AJ. β-Lactam antibiotics: mode of action and bacterial resistance. In: Lorian V, ed. Antibiotics in laboratory medicine. 3rd ed. Baltimore: Williams & Wilkins, 1991:648.
9. Benno Y, Suzuki K, Suzuki K, Narisawa K, Bruce WR, Mitsuoka T. Comparison of the fecal microflora in rural Japanese and urban Canadians. Microbiol Immunol 1986;30:521-32.